The effect of positive expiratory pressure (PEP) therapy on symptoms, quality of life and incidence of re-exacerbation in patients with acute exacerbations of chronic obstructive pulmonary disease: a multicentre, randomised controlled trial

Christian Osadnik, Christine F McDonald, Belinda Miller, Catherine Hill, Ben Tarrant, Ranjana Steward, Caroline Chao, Nicole Stodden, Cristino C Oliveira, Nadia Gagliardi, Anne E Holland

Research output: Contribution to journalArticleResearchpeer-review

23 Citations (Scopus)

Abstract

Positive expiratory pressure (PEP) is a technique used to enhance sputum clearance during acute exacerbations of chronic obstructive pulmonary disease (AECOPD). The impact of PEP therapy during acute exacerbations on clinically important outcomes is not clear. This study sought to determine the effect of PEP therapy on symptoms, quality of life and future exacerbations in patients with AECOPD.
Original languageEnglish
Pages (from-to)137-143
Number of pages7
JournalThorax
Volume69
Issue number2
DOIs
Publication statusPublished - 2014

Cite this